125 related articles for article (PubMed ID: 2155476)
1. Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis.
Seppälä E; Nissilä M; Isomäki H; Wuorela H; Vapaatalo H
Scand J Rheumatol; 1990; 19(1):71-5. PubMed ID: 2155476
[TBL] [Abstract][Full Text] [Related]
2. [Leukotriene B4, leukotriene C4 and prostaglandin E2 in the serum, synovial fluid and synovium in patients with rheumatoid arthritis].
Sawazaki Y
Nihon Ika Daigaku Zasshi; 1989 Dec; 56(6):559-64. PubMed ID: 2558123
[TBL] [Abstract][Full Text] [Related]
3. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment.
Daymond TJ; Rowell FJ
Drugs; 1988; 35 Suppl 1():4-8. PubMed ID: 3162870
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.
Seppälä E; Nissilä M; Isomäki H; Nuotio P; Nykänen E; Laitinen O; Vapaatalo H
Clin Rheumatol; 1985 Sep; 4(3):315-20. PubMed ID: 3864577
[TBL] [Abstract][Full Text] [Related]
5. Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids.
Ahmadzadeh N; Shingu M; Nobunaga M; Tawara T
Inflammation; 1991 Dec; 15(6):497-503. PubMed ID: 1661709
[TBL] [Abstract][Full Text] [Related]
6. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.
Bertin P; Lapicque F; Payan E; Rigaud M; Bailleul F; Jaeger S; Treves R; Netter P
Eur J Clin Pharmacol; 1994; 46(1):3-7. PubMed ID: 8005184
[TBL] [Abstract][Full Text] [Related]
7. The metabolism of synthetic leukotriene B4 in synovial fluid and whole human blood.
Forrest MJ; Burton D; Brooks PM
Prostaglandins; 1987 Sep; 34(3):433-43. PubMed ID: 2829280
[TBL] [Abstract][Full Text] [Related]
8. 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4).
Fogh K; Hansen ES; Herlin T; Knudsen V; Henriksen TB; Ewald H; Bünger C; Kragballe K
Prostaglandins; 1989 Feb; 37(2):213-28. PubMed ID: 2543035
[TBL] [Abstract][Full Text] [Related]
9. Effects of pirazolac on arachidonic acid metabolism in the human synovial system.
Kurowski M; Dunky A; Geddawi M
Curr Med Res Opin; 1987; 10(7):494-501. PubMed ID: 3040340
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.
Davidson EM; Rae SA; Smith MJ
Ann Rheum Dis; 1983 Dec; 42(6):677-9. PubMed ID: 6316858
[TBL] [Abstract][Full Text] [Related]
11. The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis.
Prete PE; Gurakar-Osborne A
Prostaglandins; 1997 Oct; 54(4):689-98. PubMed ID: 9440132
[TBL] [Abstract][Full Text] [Related]
12. Eicosanoid production in rheumatoid synovitis.
Moilanen E; Alanko J; Nissilä M; Hämäläinen M; Isomäki H; Vapaatalo H
Agents Actions; 1989 Nov; 28(3-4):290-7. PubMed ID: 2556902
[TBL] [Abstract][Full Text] [Related]
13. Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.
Moilanen E
Agents Actions; 1989 Mar; 26(3-4):342-9. PubMed ID: 2786669
[TBL] [Abstract][Full Text] [Related]
14. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.
Sacerdote P; Carrabba M; Galante A; Pisati R; Manfredi B; Panerai AE
Inflamm Res; 1995 Nov; 44(11):486-90. PubMed ID: 8597883
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis.
Blackburn WD; Heck LW; Loose LD; Eskra JD; Carty TJ
Arthritis Rheum; 1991 Feb; 34(2):204-10. PubMed ID: 1847289
[TBL] [Abstract][Full Text] [Related]
16. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis.
Caccavo D; Sebastiani GD; Di Monaco C; Guido F; Galeazzi M; Ferri GM; Bonomo L; Afeltra A
Int J Clin Lab Res; 1999; 29(1):30-5. PubMed ID: 10356661
[TBL] [Abstract][Full Text] [Related]
18. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses.
Owens JG; Kamerling SG; Stanton SR; Keowen ML; Prescott-Mathews JS
Am J Vet Res; 1996 Jun; 57(6):866-74. PubMed ID: 8725815
[TBL] [Abstract][Full Text] [Related]
19. Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits.
Novaes GS; Mello SB; Laurindo IM; Cossermelli W
J Rheumatol; 1996 Dec; 23(12):2092-7. PubMed ID: 8970046
[TBL] [Abstract][Full Text] [Related]
20. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid.
Punzi L; Schiavon F; Cavasin F; Ramonda R; Gambari PF; Todesco S
Clin Exp Rheumatol; 1989; 7(3):247-50. PubMed ID: 2547540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
